p53 mediates cigarette smoke-induced apoptosis of pulmonary endothelial cells inhibitory effects of macrophage migration inhibitor factor

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 3, 2011, Pages 323-332

  Damico, Rachel ^a   Simms, Tiffany ^a   Kim, Bo S ^a   Tekeste, Zenar ^a   Amankwan, Henry ^a   Damarla, Mahendra ^a   Hassoun, Paul M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cigarette; Endothelial cells; Macrophage migration inhibitory factor; p53

Indexed keywords

BINDING PROTEIN; CASPASE 9; CIGARETTE SMOKE; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LUNG BLOOD VESSEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VASCULAR ENDOTHELIUM;

APOPTOSIS; CASPASE 9; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; MACROPHAGE MIGRATION-INHIBITORY FACTORS; PEPTIDE HYDROLASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952234493     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0379OC     Document Type: Article

References (45)

1. Mannino D, Buist AS. Global burden of COPD: risk factors, prevalence, future trends. Lancet 2007;370:765-773. (Pubitemid 47321908)
2. Calabrese F, Giacometti C, Beghe B, Rea F, Loy M, Zuin R, Marulli G, Baraldo S, Saetta M, Valente M. Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir Res 2005;6:14.
3. Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004;125:626-632. (Pubitemid 38223645)
4. Marwick JA, Stevenson CS, Giddings J, MacNee W, Butler K, Rahman I, Kirkham PA. Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition. Am J Physiol Lung Cell Mol Physiol 2006;290:L897-L908. (Pubitemid 43725052)
5. Henson PM, Cosgrove GP, Vandivier RW. State of the art: apoptosis and cell homeostasis in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:512-516. (Pubitemid 44285539)
6. Henson PM, Vandivier RW, Douglas IS. Cell death, remodeling, and repair in chronic obstructive pulmonary disease? Proc Am Thorac Soc 2006;3:713-717.
7. Demedts I, Demoor T, Bracke K, Joos G, Brusselle G. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006;7:53.
8. Imai K, Mercer BA, Schulman LL, Sonett JR, D'Armiento JM. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J 2005;25:250-258. (Pubitemid 40246524)
9. Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003;29:88-97. (Pubitemid 36783320)
10. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106:1311-1319.
11. Nana-Sinkam SP, Lee JD, Sotto-Santiago S, Stearman RS, Keith RL, Choudhury Q, Cool C, Parr J, Moore MD, Bull TM, et al. Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. Am J Respir Crit Care Med 2007;175:676-685. (Pubitemid 46536482)
12. Shigemura N, Sawa Y, Mizuno S, Ono M, Ohta M, Nakamura T, Kaneda Y, Matsuda H. Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats. Circulation 2005;111:1407-1414. (Pubitemid 40396807)
13. Taraseviciene-Stewart L, Scerbavicius R, Choe K-H, Moore M, Sullivan A, Nicolls MR, Fontenot AP, Tuder RM, Voelkel NF. An animal model of autoimmune emphysema. Am J Respir Crit Care Med 2005;171:734-742. (Pubitemid 40471144)
14. Petrache I, Fijalkowska I, Zhen L, Medler TR, Brown E, Cruz P, Choe K-H, Taraseviciene-Stewart L, Scerbavicius R, Shapiro L, et al. A novel antiapoptotic role for {alpha}1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 2006;173:1222-1228. (Pubitemid 43848392)
15. Petrache I, Natarajan V, Zhen L, Medler TR, Richter A, Berdyshev EV, Tuder RM. Ceramide causes pulmonary cell apoptosis and emphysema: a role for sphingolipid homeostasis in the maintenance of alveolar cells. Proc Am Thorac Soc 2006;3:510. (Pubitemid 44285537)
16. Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009;458:1127-1130.
17. Morissette MC, Vachon-Beaudoin G, Parent J, Chakir J, Milot J. Increased p53 level, Bax/Bcl-X(L) ratio, and trail receptor expression in human emphysema. Am J Respir Crit Care Med 2008;178:240-247.
18. Wu CH, Lin HH, Yan FP, Wu CH, Wang CJ. Immunohistochemical detection of apoptotic proteins, p53/Bax and Jnk/Fasl cascade, in the lung of rats exposed to cigarette smoke. Arch Toxicol 2006;80:328-336.
19. Arif E, Vibhuti A, Deepak D, Singh B, Siddiqui MS, Pasha MA. Cox2 and p53 risk-alleles coexist in COPD. Clin Chim Acta 2008;397:48-50.
20. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999;190:1375-1382.
21. Damico RL, Chesley A, Johnston L, Bind EP, Amaro E, Nijmeh J, Karakas B, Welsh L, Pearse DB, Garcia JG, et al. Macrophage migration inhibitory factor governs endothelial cell sensitivity to LPS-induced apoptosis. Am J Respir Cell Mol Biol 2008;39:77-85. (Pubitemid 351883961)
22. Park J-W, Kim HP, Lee S-J, Wang X, Wang Y, Ifedigbo E, Watkins SC, Ohba M, Ryter SW, Vyas YM, et al. Protein kinase C{alpha} and {zeta} differentially regulate death-inducing signaling complex formation in cigarette smoke extract-induced apoptosis. J Immunology 2008;180:4668-4678.
23. Pratt MAC, Niu M-Y. Bcl-2 controls caspase activation following a p53-dependent cyclin D1-induced death signal. J Biol Chem 2003;278:14219-14229. (Pubitemid 36799970)
24. Schafer ZT, Kornbluth S. The apoptosome: physiological, developmental, and pathological modes of regulation. Dev Cell 2006;10:549-561.
25. Lalier L, Cartron P-F, Juin P, Nedelkina S, Manon S, Bechinger B, Vallette F. Bax activation and mitochondrial insertion during apoptosis. Apoptosis 2007;12:887-896. (Pubitemid 46653297)
26. Peyerl FW, Dai S, Murphy GA, Crawford F, White J, Marrack P, Kappler JW. Elucidation of some Bax conformational changes through crystallization of an antibody-peptide complex. 2006;14:447-452.
27. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999;285:1733-1737. (Pubitemid 29428873)
28. Komarova EA, Gudkov AV. Suppression of p53: a new approach to overcome side effects of antitumor therapy. Biochemistry 2000;65:41-48.
29. Komarova EA, Neznanov N, Komarov PG, Chernov MV, Wang K, Gudkov AV. p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways. J Biol Chem 2003;278:15465-15468. (Pubitemid 36799652)
30. Murphy PJ, Galigniana MD, Morishima Y, Harrell JM, Kwok RP, Ljungman M, Pratt WB. Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with HSP90 and its nuclear translocation. J Biol Chem 2004;279:30195-30201. (Pubitemid 38937944)
31. Clark I, Awburn M. Migration inhibitory factor in the cerebral and systemic endothelium in sepsis and malaria. Crit Care Med 2002;30(5, Suppl)S263-S267. (Pubitemid 34508001)
32. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000;408:211-216.
33. Wei N, Serino G, Deng XW. The COP9 signalosome: more than a protease. Trends Biochem Sci 2008;33:592-600.
34. Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N, Kato J-y. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem 2002;277:2302-2310. (Pubitemid 34968817)
35. Liu X, Pan Z, Zhang L, Sun Q, Wan J, Tian C, Xing G, Yang J, Liu X, Jiang J, et al. Jab1 accelerates mitochondrial apoptosis by interaction with proapoptotic BCLGs. Cell Signal 2008;20:230-240. (Pubitemid 350138384)
36. Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S, Kato JY. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem2004;279:43013-43018.
37. Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, Dubiel W. Cop9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 2001;20:1630-1639. (Pubitemid 32299400)
38. Zhang XC, Chen J, Su CH, Yang HY, Lee MH. Roles for CSN5 in control of p53/MDM2 activities. J Cell Biochem 2008;103:1219-1230. (Pubitemid 351342611)
39. Jung H, Seong HA, Ha H. Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem 2008;283:20383-20396.
40. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999;115:829-835. (Pubitemid 29129968)
41. Larsson L, Szponar B, Pehrson C. Tobacco smoking increases dramatically air concentrations of endotoxin. Indoor Air 2004;14:421-424. (Pubitemid 39523854)
42. Vernooy JHJ, Dentener MA, van Suylen RJ, Buurman WA, Wouters EFM. Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol 2002;26:152-159. (Pubitemid 34029832)
43. Poukkula M, Kaunisto A, Hietakangas V, Denessiouk K, Katajamaki T, Johnson MS, Sistonen L, Eriksson JE. Rapid turnover of C-FLIPshort is determined by its unique C-terminal tail. J Biol Chem 2005;280:27345-27355. (Pubitemid 41040776)
44. Rodriguez MS, Desterro JM, Lain S, Lane DP, Hay RT. Multiple Cterminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol Cell Biol 2000;20:8458-8467.
45. Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, Stevens A, Shelley E, Lamb R, Ollier WE, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002;46:2402-2409.